PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VMNIX vs. IMMX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between VMNIX and IMMX is 0.00, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.0

Performance

VMNIX vs. IMMX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vanguard Market Neutral Fund Institutional Shares (VMNIX) and Immix Biopharma, Inc. (IMMX). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%AugustSeptemberOctoberNovemberDecember2025
0.80%
-3.88%
VMNIX
IMMX

Key characteristics

Sharpe Ratio

VMNIX:

0.70

IMMX:

-0.68

Sortino Ratio

VMNIX:

1.07

IMMX:

-0.91

Omega Ratio

VMNIX:

1.12

IMMX:

0.90

Calmar Ratio

VMNIX:

1.18

IMMX:

-0.79

Martin Ratio

VMNIX:

2.50

IMMX:

-1.11

Ulcer Index

VMNIX:

1.74%

IMMX:

57.79%

Daily Std Dev

VMNIX:

6.27%

IMMX:

95.18%

Max Drawdown

VMNIX:

-25.35%

IMMX:

-88.89%

Current Drawdown

VMNIX:

-1.85%

IMMX:

-72.76%

Returns By Period

In the year-to-date period, VMNIX achieves a 1.52% return, which is significantly higher than IMMX's -10.00% return.


VMNIX

YTD

1.52%

1M

1.02%

6M

0.81%

1Y

4.90%

5Y*

8.23%

10Y*

3.33%

IMMX

YTD

-10.00%

1M

-9.17%

6M

-3.88%

1Y

-57.87%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VMNIX vs. IMMX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VMNIX
The Risk-Adjusted Performance Rank of VMNIX is 3636
Overall Rank
The Sharpe Ratio Rank of VMNIX is 2828
Sharpe Ratio Rank
The Sortino Ratio Rank of VMNIX is 3131
Sortino Ratio Rank
The Omega Ratio Rank of VMNIX is 2323
Omega Ratio Rank
The Calmar Ratio Rank of VMNIX is 6969
Calmar Ratio Rank
The Martin Ratio Rank of VMNIX is 3131
Martin Ratio Rank

IMMX
The Risk-Adjusted Performance Rank of IMMX is 1212
Overall Rank
The Sharpe Ratio Rank of IMMX is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of IMMX is 1212
Sortino Ratio Rank
The Omega Ratio Rank of IMMX is 1414
Omega Ratio Rank
The Calmar Ratio Rank of IMMX is 55
Calmar Ratio Rank
The Martin Ratio Rank of IMMX is 1818
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VMNIX vs. IMMX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Vanguard Market Neutral Fund Institutional Shares (VMNIX) and Immix Biopharma, Inc. (IMMX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VMNIX, currently valued at 0.70, compared to the broader market-1.000.001.002.003.004.000.70-0.68
The chart of Sortino ratio for VMNIX, currently valued at 1.07, compared to the broader market0.005.0010.001.07-0.91
The chart of Omega ratio for VMNIX, currently valued at 1.12, compared to the broader market1.002.003.004.001.120.90
The chart of Calmar ratio for VMNIX, currently valued at 1.18, compared to the broader market0.005.0010.0015.0020.001.18-0.79
The chart of Martin ratio for VMNIX, currently valued at 2.50, compared to the broader market0.0020.0040.0060.0080.00100.002.50-1.11
VMNIX
IMMX

The current VMNIX Sharpe Ratio is 0.70, which is higher than the IMMX Sharpe Ratio of -0.68. The chart below compares the historical Sharpe Ratios of VMNIX and IMMX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
0.70
-0.68
VMNIX
IMMX

Dividends

VMNIX vs. IMMX - Dividend Comparison

VMNIX's dividend yield for the trailing twelve months is around 5.59%, while IMMX has not paid dividends to shareholders.


TTM2024202320222021202020192018201720162015
VMNIX
Vanguard Market Neutral Fund Institutional Shares
5.59%5.67%5.15%0.78%0.20%0.85%3.22%1.00%1.16%0.45%0.10%
IMMX
Immix Biopharma, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

VMNIX vs. IMMX - Drawdown Comparison

The maximum VMNIX drawdown since its inception was -25.35%, smaller than the maximum IMMX drawdown of -88.89%. Use the drawdown chart below to compare losses from any high point for VMNIX and IMMX. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-1.85%
-72.76%
VMNIX
IMMX

Volatility

VMNIX vs. IMMX - Volatility Comparison

The current volatility for Vanguard Market Neutral Fund Institutional Shares (VMNIX) is 1.88%, while Immix Biopharma, Inc. (IMMX) has a volatility of 18.28%. This indicates that VMNIX experiences smaller price fluctuations and is considered to be less risky than IMMX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
1.88%
18.28%
VMNIX
IMMX
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab